Extendicare (TSE:EXE – Get Free Report) had its price target dropped by investment analysts at National Bank Financial from C$45.00 to C$40.00 in a research report issued to clients and investors on Wednesday, BayStreet reports. The brokerage presently has an “outperform” rating on the stock. National Bank Financial’s price objective points to a potential upside of 46.95% from the stock’s current price.
Several other research analysts have also issued reports on EXE. Canaccord Genuity Group raised their target price on shares of Extendicare from C$37.00 to C$44.00 and gave the company a “buy” rating in a research note on Monday, August 10th. Desjardins lowered their price target on shares of Extendicare from C$40.00 to C$39.00 and set a “buy” rating for the company in a research report on Monday, August 10th. Finally, Royal Bank Of Canada lifted their price target on shares of Extendicare from C$38.00 to C$39.00 and gave the stock an “outperform” rating in a research report on Friday, August 14th. Seven research analysts have rated the stock with a Buy rating. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of C$37.00.
Read Our Latest Stock Report on Extendicare
Extendicare Trading Down 0.9%
EXE stock traded down C$0.26 during midday trading on Wednesday, reaching C$27.22. The stock had a trading volume of 261,802 shares, compared to its average volume of 439,499. The business has a fifty day simple moving average of C$30.04 and a two-hundred day simple moving average of C$32.12. The company has a quick ratio of 0.98, a current ratio of 0.75 and a debt-to-equity ratio of 159.54. The firm has a market cap of C$2.59 billion, a price-to-earnings ratio of 20.84 and a beta of 1.39. Extendicare has a twelve month low of C$15.30 and a twelve month high of C$39.14.
Extendicare (TSE:EXE – Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported C$0.38 earnings per share for the quarter. The firm had revenue of C$611.04 million during the quarter. Extendicare had a return on equity of 36.33% and a net margin of 6.13%. As a group, research analysts expect that Extendicare will post 0.61 EPS for the current fiscal year.
Extendicare Company Profile
Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. We are committed to delivering quality care to meet the needs of the growing seniors’ population, inspired by our mission to provide people with the care they need, wherever they call home. We deliver more than 27 million hours of home health care services annually, operate a network of 97 long-term care homes (58 owned, 39 under management contracts), and provide group purchasing services to third parties representing approximately 161,700 beds across Canada.
Further Reading
- Five stocks we like better than Extendicare
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
